Patents by Inventor Klaus Hardebeck

Klaus Hardebeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition and method for the treatment of hydropic conditions
    Patent number: 4031213
    Abstract: Pharmaceutical compositions comprisingA. at least one member of 5-(4-chloro-5-sulfamoyl-2-thenylaminophenyl)-tetrazole and the pharmacologically compatible salts thereof,B. 3-(3-oxo-7.alpha.-acetylthio-17.beta.-hydroxy-4-androsten-17.alpha.-yl)-pr opionic acid-.gamma.-lactone, andC. a pharmaceutical diluent or carrierPossess outstanding activity for treating hydropic conditions and prevent undesirable increased excretion of potassium without at the same time impairing the desired excretion of water and sodium.
    Type: Grant
    Filed: April 16, 1975
    Date of Patent: June 21, 1977
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Rolf Kuhn, Klaus Hardebeck, Helmut Heinemann
  • 3-Alkyl-4-sulfamoyl-aniline therapeutic compositions
    Patent number: 3991188
    Abstract: New 3-alkyl-4-sulfamoyl-aniline compounds of the formula ##SPC1##WhereinR.sub.1 is phenyl, furyl or thienyl;R.sub.2 is carboxyl or tetrazolyl-(5)R.sub.4 is a straight-chain or branched alkyl radical of from 2 to 5 carbon atoms; andn is 1 or 2;And the pharmacologically compatible salts thereof; are outstandingly effective saluretic compounds, particularly when administered enterally.
    Type: Grant
    Filed: July 3, 1975
    Date of Patent: November 9, 1976
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Ansgar Lerch, Alfred Popelak, Kurt Stach, Egon Roesch, Klaus Hardebeck
  • Pharmaceutical compositions for the treatment of hydropic conditions
    Patent number: 3963834
    Abstract: Pharmaceutical compositions comprisingA. at least one member of the group consiting of 5-(4-chloro-5-sulfamoyl-2-thenylaminophenyl)-tetrazole and the pharmacologically compatible salts thereofB. at least one member of the group consisting of 3-(3-oxo-17.beta.-hydroxy-4,6-androstadien-17.alpha.-yl)-propionic acid-.gamma.-lactone and the pharmacologically compatible salts of 3-(3-oxo-17.beta.-hydoxy-4,6-androstadien-17.alpha.-yl)-propionic acid, and a pharmaceutical carrier;Possess outstanding activity for treating hydropic conditions and prevent undesirable increased excretion of potassium without at the same time impairing the desired excretion of water and sodium.
    Type: Grant
    Filed: April 18, 1975
    Date of Patent: June 15, 1976
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Rolf Kuhn, Klaus Hardebeck, Helmut Heinemann, Knut Osmers
  • Biphenyl compounds
    Patent number: 3959261
    Abstract: Novel biphenyl derivatives of the formula: ##SPC1##WhereinR.sub.1 is phenyl, furyl or thienyl; andR.sub.2 is carboxyl or tetrazolyl-(5);And the pharmacologically compatible salts thereof display outstanding diuretic and saluretic properties.
    Type: Grant
    Filed: June 25, 1974
    Date of Patent: May 25, 1976
    Assignee: Boehringer Mannheim GmbH
    Inventors: Ansgar Lerch, Alfred Popelak, Kurt Stach, Klaus Hardebeck, Wolfgang Schaumann